New drug could help stop the spread of disease during cough: research

Sep 22, 2010

What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs? Researchers at the University of Alberta believe they have found a way to achieve this.

The idea behind this work came from Malcolm King and his research associate Gustavo Zayas, who work in the Division of Pulmonary Medicine at the U of A's Faculty of Medicine & Dentistry. King and Zayas developed a drug that, when inhaled, would reduce or eliminate the amount of droplets, called bioaerosol, coming out of the mouth when a disease-infected person . These airborne particles can stay in the air for minutes and sometimes even hours.

In order to help perfect this drug King and Zayas enlisted in the expertise of PhD student Anwarul Hasan and associate professor Carlos Lange, both from the Faculty of Engineering's mechanical engineering department. It was Hasan and Lange's role to find out how the size and amount of the cough-emitted droplets are affected by the new drug.

After five years of research, using a simulated cough machine, Hasan discovered how the new drug can manipulate the properties of the lung fluid to almost completely suppress the emission of droplets, a research first. This discovery provides a clear target for the new drug in its early phases of development.

King and Zayas are moving forward to develop the drug in the form of a spray and plan to perform clinical trials in hopes that one day this could not only help stop the spread of a pandemic outbreak, but also protect nurses, doctors and other front-line health care professionals.

Explore further: Scientists restore hearing in noise-deafened mice, pointing way to new therapies

More information: This research was recently published in the journal Non-Newtonian Fluid Mechanics and can be found here: dx.doi.org/10.1016/j.jnnfm.2010.07.005

add to favorites email to friend print save as pdf

Related Stories

FDA cracks down on hydrocone products

Sep 29, 2007

The U.S. Food and Drug Administration says it will start taking enforcement action against companies marketing unapproved hydrocodone products.

Drug companies accused of manipulation

Aug 07, 2006

Pharmaceutical companies are compromising medical research in Australia by manipulating clinical trials, The Age newspaper reported Monday.

Regal King seafood dips recalled

Aug 20, 2007

The U.S. Food and Drug Administration has announced the recall of Regal King brands ready-to-eat seafood dips because of possible Listeria contamination.

Pfizer drug found with serious side effect

Nov 01, 2006

U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Recommended for you

Team untangles the biological effects of blue light

7 hours ago

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...

Mouse model provides new insight in to preeclampsia

7 hours ago

Worldwide, preeclampsia is a leading cause of maternal deaths and preterm births. This serious pregnancy complication results in extremely high blood pressure and organ damage. The onset of preeclampsia is associated with ...

Scientists unravel the mystery of a rare sweating disorder

7 hours ago

An international research team discovered that mutation of a single gene blocks sweat production, a dangerous condition due to an increased risk of hyperthermia, also known as heatstroke. The gene, ITPR2, controls a basic ...

User comments : 0